News & Updates

6-month resistance training eases platelet activation in hypertensive women

18 Nov 2023

Resistance training is effective in reducing platelet aggregation by modulating the purinergic system in hypertensive women, suggests a recent study, which shows an association between purinergic signaling and platelet activation in hypertension.

6-month resistance training eases platelet activation in hypertensive women

18 Nov 2023

Torsemide as good as furosemide for treating de novo, chronic heart failure

18 Nov 2023

Among patients with heart failure (HF), those who have de novo HF have better outcomes than those who have worsening chronic HF status, but treatment with torsemide yields 12-month outcomes that are similar to that observed with furosemide regardless of HF type, according to a post hoc analysis of the TRANSFORM-HF trial.

Torsemide as good as furosemide for treating de novo, chronic heart failure

18 Nov 2023

TAVR outperforms surgery through 4 years in low-risk patients with severe AS

17 Nov 2023 by

Among low surgical-risk patients with severe aortic stenosis (AS), those who underwent transcatheter aortic valve replacement (TAVR) have better valve performance and clinical and haemodynamic outcomes up to 4 years compared with those who underwent surgical aortic valve replacement (SAVR), according to the EVOLUT Low Risk trial presented at TCT 2023.

TAVR outperforms surgery through 4 years in low-risk patients with severe AS

17 Nov 2023

Low-sodium diet delivers rapid BP-lowering effect

16 Nov 2023 by

In the CARDIA-SSBP study, low sodium intake led to a rapid reduction in blood pressure (BP) in middle-aged individuals.

Low-sodium diet delivers rapid BP-lowering effect

16 Nov 2023

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

New drug applications approved by US FDA as of 01-15 November 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

Paclitaxel-coated devices do not increase mortality risk

14 Nov 2023 by

An updated patient-level meta-analysis refutes claims that paclitaxel-coated devices for femoropopliteal interventional procedures heighten the risk of death. The recent study presented at TCT 2023 has found no association between exposure to paclitaxel and mortality.

Paclitaxel-coated devices do not increase mortality risk

14 Nov 2023

Shorter outshines longer DAPT for ACS patients following DES implantation

14 Nov 2023 by

In patients treated with drug-eluting stents (DES) for acute coronary syndrome (ACS), stopping aspirin within a month of dual antiplatelet therapy (DAPT) and continuing with ticagrelor alone outdid a 12-month DAPT regimen with ticagrelor and aspirin, findings from the T-PASS trial have shown.

Shorter outshines longer DAPT for ACS patients following DES implantation

14 Nov 2023

Women fare better than men after Impella-assisted HR PCI

13 Nov 2023 by

Women undergoing high-risk percutaneous coronary intervention (HR PCI) appear to have better survival outcomes following hospital discharge compared with men, despite being older and having a more complex coronary artery disease, according to data from the IMPELLA-PL registry.

Women fare better than men after Impella-assisted HR PCI

13 Nov 2023

Deep learning-enabled echocardiographic readings help predict CV outcomes

13 Nov 2023

Deep learning interpretation of echocardiographic images demonstrates accurate readings of standard measures of left heart structure and function, which are predictive of cardiovascular (CV) outcomes, reports a recent study.

Deep learning-enabled echocardiographic readings help predict CV outcomes

13 Nov 2023

Is TAVR better than surgery for aortic stenosis patients?

13 Nov 2023 by

Treatment with transcatheter aortic-valve replacement (TAVR) or surgery in low-risk patients with severe, symptomatic aortic stenosis results in similar and low clinical event rates at 5 years, according to the results of the PARTNER 3 study.

Is TAVR better than surgery for aortic stenosis patients?

13 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

6-month resistance training eases platelet activation in hypertensive women

6-month resistance training eases platelet activation in hypertensive women

Torsemide as good as furosemide for treating de novo, chronic heart failure

Torsemide as good as furosemide for treating de novo, chronic heart failure

TAVR outperforms surgery through 4 years in low-risk patients with severe AS

TAVR outperforms surgery through 4 years in low-risk patients with severe AS

Low-sodium diet delivers rapid BP-lowering effect

Low-sodium diet delivers rapid BP-lowering effect

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Paclitaxel-coated devices do not increase mortality risk

Paclitaxel-coated devices do not increase mortality risk

Shorter outshines longer DAPT for ACS patients following DES implantation

Shorter outshines longer DAPT for ACS patients following DES implantation

Women fare better than men after Impella-assisted HR PCI

Women fare better than men after Impella-assisted HR PCI

Deep learning-enabled echocardiographic readings help predict CV outcomes

Deep learning-enabled echocardiographic readings help predict CV outcomes

Is TAVR better than surgery for aortic stenosis patients?

Is TAVR better than surgery for aortic stenosis patients?